TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ambit Biosciences Corp (NASDAQ:AMBI) Investor Files Lawsuit Against Acquisition By Daiichi Sankyo Company

  • If you purchased shares of Ambit Biosciences Corp (NASDAQ:AMBI) and currently hold any of those NASDAQ:AMBI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

October 13, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Ambit Biosciences Corp (NASDAQ:AMBI), filed a lawsuit in effort to halt the proposed takeover of Ambit Biosciences Corp. by Daiichi Sankyo Company for $15 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:AMBI stockholders by agreeing to sell Ambit...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: